These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 17141227)

  • 1. Plasma fatty acid metabolic profiling and biomarkers of type 2 diabetes mellitus based on GC/MS and PLS-LDA.
    Yi LZ; He J; Liang YZ; Yuan DL; Chau FT
    FEBS Lett; 2006 Dec; 580(30):6837-45. PubMed ID: 17141227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneously quantitative measurement of comprehensive profiles of esterified and non-esterified fatty acid in plasma of type 2 diabetic patients.
    Yi L; He J; Liang Y; Yuan D; Gao H; Zhou H
    Chem Phys Lipids; 2007 Dec; 150(2):204-16. PubMed ID: 17880934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma esterified and non-esterified fatty acids metabolic profiling using gas chromatography-mass spectrometry and its application in the study of diabetic mellitus and diabetic nephropathy.
    Han LD; Xia JF; Liang QL; Wang Y; Wang YM; Hu P; Li P; Luo GA
    Anal Chim Acta; 2011 Mar; 689(1):85-91. PubMed ID: 21338761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Free fatty acid metabolic profile and biomarkers of isolated post-challenge diabetes and type 2 diabetes mellitus based on GC-MS and multivariate statistical analysis.
    Liu L; Li Y; Guan C; Li K; Wang C; Feng R; Sun C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Oct; 878(28):2817-25. PubMed ID: 20846914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma fatty acids metabolic profiling analysis of coronary heart disease based on GC-MS and pattern recognition.
    Zheng X; Shen J; Liu Q; Wang S; Cheng Y; Qu H
    J Pharm Biomed Anal; 2009 Feb; 49(2):481-6. PubMed ID: 19058943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma phospholipid metabolic profiling and biomarkers of type 2 diabetes mellitus based on high-performance liquid chromatography/electrospray mass spectrometry and multivariate statistical analysis.
    Wang C; Kong H; Guan Y; Yang J; Gu J; Yang S; Xu G
    Anal Chem; 2005 Jul; 77(13):4108-16. PubMed ID: 15987116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive two-dimensional gas chromatography/time-of-flight mass spectrometry for metabonomics: Biomarker discovery for diabetes mellitus.
    Li X; Xu Z; Lu X; Yang X; Yin P; Kong H; Yu Y; Xu G
    Anal Chim Acta; 2009 Feb; 633(2):257-62. PubMed ID: 19166731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gas chromatography/time-of-flight mass spectrometry based metabonomic approach to differentiating hypertension- and age-related metabolic variation in spontaneously hypertensive rats.
    Lu Y; A J; Wang G; Hao H; Huang Q; Yan B; Zha W; Gu S; Ren H; Zhang Y; Fan X; Zhang M; Hao K
    Rapid Commun Mass Spectrom; 2008 Sep; 22(18):2882-8. PubMed ID: 18720470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A GC-based metabonomics investigation of type 2 diabetes by organic acids metabolic profile.
    Yuan K; Kong H; Guan Y; Yang J; Xu G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 May; 850(1-2):236-40. PubMed ID: 17188584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phospholipidomic identification of potential plasma biomarkers associated with type 2 diabetes mellitus and diabetic nephropathy.
    Zhu C; Liang QL; Hu P; Wang YM; Luo GA
    Talanta; 2011 Sep; 85(4):1711-20. PubMed ID: 21872008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum fatty acid profiles using GC-MS and multivariate statistical analysis: potential biomarkers of Alzheimer's disease.
    Wang DC; Sun CH; Liu LY; Sun XH; Jin XW; Song WL; Liu XQ; Wan XL
    Neurobiol Aging; 2012 Jun; 33(6):1057-66. PubMed ID: 20980076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fast, sensitive and highly discriminant gas chromatography-mass spectrometry method for profiling analysis of fatty acids in serum.
    Sánchez-Avila N; Mata-Granados JM; Ruiz-Jiménez J; Luque de Castro MD
    J Chromatogr A; 2009 Oct; 1216(40):6864-72. PubMed ID: 19729166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of possible biomarkers for breast cancer from free fatty acid profiles determined by GC-MS and multivariate statistical analysis.
    Lv W; Yang T
    Clin Biochem; 2012 Jan; 45(1-2):127-33. PubMed ID: 22061338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma metabolomics reveals biomarkers of the atherosclerosis.
    Chen X; Liu L; Palacios G; Gao J; Zhang N; Li G; Lu J; Song T; Zhang Y; Lv H
    J Sep Sci; 2010 Sep; 33(17-18):2776-83. PubMed ID: 20730840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gas chromatography-mass spectrometry-based profiling of serum fatty acids in acetaminophen-induced liver injured rats.
    Xiong YH; Xu Y; Yang L; Wang ZT
    J Appl Toxicol; 2014 Feb; 34(2):149-57. PubMed ID: 23239188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved fatty acid detection in micro-algae and aquatic meiofauna species using a direct thermal desorption interface combined with comprehensive gas chromatography-time-of-flight mass spectrometry.
    Akoto L; Stellaard F; Irth H; Vreuls RJ; Pel R
    J Chromatogr A; 2008 Apr; 1186(1-2):254-61. PubMed ID: 18295771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discrimination of type 2 diabetes mellitus corresponding to different traditional Chinese medicine syndromes based on plasma fatty acid profiles and chemometric methods.
    Xu W; Zhang L; Huang Y; Yang Q; Xiao H; Zhang D
    J Ethnopharmacol; 2012 Sep; 143(2):463-8. PubMed ID: 22820238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discrimination of Type 2 diabetic patients from healthy controls by using metabonomics method based on their serum fatty acid profiles.
    Yang J; Xu G; Hong Q; Liebich HM; Lutz K; Schmülling RM; Wahl HG
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Dec; 813(1-2):53-8. PubMed ID: 15556515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum metabolic profiling of abnormal savda by liquid chromatography/mass spectrometry.
    Yin P; Mohemaiti P; Chen J; Zhao X; Lu X; Yimiti A; Upur H; Xu G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Aug; 871(2):322-7. PubMed ID: 18556250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of safety biomarkers for atorvastatin in rat urine using mass spectrometry based metabolomics combined with global and targeted approach.
    Kumar BS; Lee YJ; Yi HJ; Chung BC; Jung BH
    Anal Chim Acta; 2010 Feb; 661(1):47-59. PubMed ID: 20113715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.